CONTRAFECT
ContraFect is a biotechnology company pioneering the use of monoclonal antibodies to treat life-threatening infectious diseases. It addresses multi-drug resistant infections using therapeutic products from its lysin and monoclonal antibody platforms to target the conserved regions of either bacteria or viruses. Its novel lysins are enzymes that are produced in the life cycle stage of bacteriophage, a virus that infects and kills bacteria. The company was founded in 2008 and is headquartered in Yonkers, New York.
CONTRAFECT
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2008-01-01
Address:
Yonkers, New York, United States
Country:
United States
Website Url:
http://www.contrafect.com
Total Employee:
11+
Status:
Active
Contact:
9142072300
Total Funding:
380.83 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Similar Organizations
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Concert Pharmaceuticals
Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates.
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CARB-X
CARB-X investment in Grant - ContraFect
Congressionally Directed Medical Research Programs
Congressionally Directed Medical Research Programs investment in Grant - ContraFect
CARB-X
CARB-X investment in Grant - ContraFect
CARB-X
CARB-X investment in Grant - ContraFect
CARB-X
CARB-X investment in Grant - ContraFect
U.S. Department of Defense
U.S. Department of Defense investment in Grant - ContraFect
Maxim Group
Maxim Group investment in Venture Round - ContraFect
Equity Source Partners
Equity Source Partners investment in Venture Round - ContraFect
Official Site Inspections
http://www.contrafect.com Semrush global rank: 1.26 M Semrush visits lastest month: 23.87 K
- Host name: 172.66.43.32
- IP address: 172.66.43.32
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ContraFect"
ContraFect - Crunchbase Company Profile & Funding
ContraFect is a biotechnology company pioneering the use of monoclonal antibodies to treat life-threatening infectious diseases. It addresses multi-drug resistant infections using therapeutic …See details»
ContraFect 2025 Company Profile: Valuation, Funding …
ContraFect Corp is a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and …See details»
ContraFect Corp - LinkedIn
ContraFect Corp | 3,498 followers on LinkedIn. ...focused on discovering & developing differentiated biologic therapies for life-threatening, drug-resistant infections | We are a …See details»
ContraFect Company Profile - Office Locations, Competitors, …
Jul 18, 2024 ContraFect is a clinical stage biotechnology company focused on discovering and developing therapeutic proteins and antibodies for life-threatening, drug-resistant infectious …See details»
Contrafect Corp - AnnualReports.com
Contrafect Corp is a biotechnology company focused on developing treatments for drug resistant, life-threatening infectious diseases. Contrafect Corp lysin and monoclonal antibody products …See details»
ContraFect (CFRXQ) Company Profile & Description - Stock Analysis
Apr 11, 2025 ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. On December 4, 2023, ContraFect Corporation filed a voluntary petition …See details»
ContraFect Company Profile | Management and Employees List
ContraFect Profile and History. ContraFect is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant …See details»
ContraFect - businessabc.net
Feb 25, 2025 ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. History ContraFect was founded in 2008 in Yonkers, New York as a …See details»
ContraFect - The Org
ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of …See details»
ContraFect Corporation - VentureRadar
ContraFect is a biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the …See details»
ContraFect - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 9, 2025 ContraFect is a public company based in Yonkers (United States), founded in 2008. It operates as a Develops proteins and antibodies for drug-resistant infectious diseases. …See details»
ContraFect Corp: Revenue, Worth, Valuation & Competitors 2024
About ContraFect Corp. ContraFect Corp is a Biotech related company founded in 2008 and based in Yonkers with an estimated revenue of $7.5M, and 32 employees. It has 10 …See details»
ContraFect Corporation - SSG Capital Advisors LLC
ContraFect Corporation. Client Profile. ContraFect Corporation was a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including …See details»
ContraFect
ContraFect is a clinical-stage biotechnology company focused on discovering and developing biologic therapies for life-threatening, drug-resistant infectious diseases, particularly those …See details»
News at ContraFect - The Official Board
ContraFect has 2,237 competitors including Navitas Life Sciences (India), Adaptive Phage Therapeutics (United States (USA)) and Eurofins (Luxembourg). Popular M&A news in …See details»
ContraFect - Bacteriophage.news
May 12, 2021 ContraFect is a clinical-stage biotechnology company focused on discovering and developing biological therapies for life-threatening, drug-resistant infectious diseases, …See details»
ContraFect Corp (CFRXQ) Company Information - Hargreaves …
ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin …See details»
CONTRAFECT Corp Company Research Report - askcyborg.com
CONTRAFECT Corp is a pioneering biotechnology company dedicated to addressing the urgent need for novel and effective treatments against life-threatening,See details»
CONTRAFECT CORPORATION Bankruptcy Filing Details
Dec 4, 2023 ContraFect Corporation 28 Wells Avenue 3rd Floor Yonkers, NY 10701 WESTCHESTER-NY Tax ID / EIN: 39-2072586 aka ContraFect Corp. aka ContraFect: rep. by …See details»
CFRXQ | ContraFect Corp. Stock Overview (U.S.: OTC) - Barron's
Apr 23, 2025 Complete ContraFect Corp. stock information by Barron's. View real-time CFRXQ stock price and news, along with industry-best analysis.See details»